117 related articles for article (PubMed ID: 3298077)
1. Defective expression of MHC class I antigens is frequent in B-cell lymphomas of high-grade malignancy.
Möller P; Herrmann B; Moldenhauer G; Momburg F
Int J Cancer; 1987 Jul; 40(1):32-9. PubMed ID: 3298077
[TBL] [Abstract][Full Text] [Related]
2. B-cell lymphomas of high-grade malignancy frequently lack HLA-DR, -DP and -DQ antigens and associated invariant chain.
Momburg F; Herrmann B; Moldenhauer G; Möller P
Int J Cancer; 1987 Nov; 40(5):598-603. PubMed ID: 3316049
[TBL] [Abstract][Full Text] [Related]
3. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
4. The primary mediastinal clear cell lymphoma of B-cell type has variable defects in MHC antigen expression.
Möller P; Lämmler B; Herrmann B; Otto HF; Moldenhauer G; Momburg F
Immunology; 1986 Nov; 59(3):411-7. PubMed ID: 3491784
[TBL] [Abstract][Full Text] [Related]
5. Histocompatibility antigens in primary and metastatic squamous cell carcinoma of the larynx.
Esteban F; Concha A; Huelin C; Pérez-Ayala M; Pedrinaci S; Ruiz-Cabello F; Garrido F
Int J Cancer; 1989 Mar; 43(3):436-42. PubMed ID: 2647639
[TBL] [Abstract][Full Text] [Related]
6. Immunohistologic characterization of two malignant lymphomas of germinal center type (centroblastic/centrocytic and centrocytic) with monoclonal antibodies. Follicular and diffuse lymphomas of small-cleaved-cell type are related but distinct entities.
Harris NL; Nadler LM; Bhan AK
Am J Pathol; 1984 Nov; 117(2):262-72. PubMed ID: 6437232
[TBL] [Abstract][Full Text] [Related]
7. Major histocompatibility complex class I and class II antigen expression in diffuse large cell and large cell immunoblastic lymphomas. Absence of a correlation between antigen expression and clinical outcome.
Medeiros LJ; Gelb AB; Wolfson K; Doggett R; McGregor B; Cox RS; Horning SJ; Warnke RA
Am J Pathol; 1993 Oct; 143(4):1086-97. PubMed ID: 8214004
[TBL] [Abstract][Full Text] [Related]
8. Characterization of B-cell non-Hodgkin's lymphomas. A study using a panel of monoclonal and heterologous antibodies.
van der Valk P; Jansen J; Daha MR; Meijer CJ
Virchows Arch A Pathol Anat Histopathol; 1983; 401(3):289-305. PubMed ID: 6195805
[TBL] [Abstract][Full Text] [Related]
9. Nature of non-B, non-T lymphomas: an immunohistological study on frozen tissues using monoclonal antibodies.
Pallesen G; Beverley PC; Lane EB; Madsen M; Mason DY; Stein H
J Clin Pathol; 1984 Aug; 37(8):911-8. PubMed ID: 6381546
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical analysis of human MHC class II antigens in B-cell non-Hodgkin's lymphomas.
Krajewski AS; Guy K; Dewar AE; Cossar D
J Pathol; 1985 Feb; 145(2):185-94. PubMed ID: 2579225
[TBL] [Abstract][Full Text] [Related]
11. Primary gastrointestinal malignant lymphomas. A morphologic and immunohistochemical study.
Papadimitriou CS; Papacharalampous NX; Kittas C
Cancer; 1985 Feb; 55(4):870-9. PubMed ID: 3917844
[TBL] [Abstract][Full Text] [Related]
12. High numbers of tumour-infiltrating activated cytotoxic T lymphocytes, and frequent loss of HLA class I and II expression, are features of aggressive B cell lymphomas of the brain and testis.
Riemersma SA; Oudejans JJ; Vonk MJ; Dreef EJ; Prins FA; Jansen PM; Vermeer MH; Blok P; Kibbelaar RE; Muris JJ; Schuuring EM; Kluin PM
J Pathol; 2005 Jul; 206(3):328-36. PubMed ID: 15887291
[TBL] [Abstract][Full Text] [Related]
13. [Retrospective analysis of the clinical relevance of the Kiel classification of malignant non-Hodgkin's lymphomas (author's transl)].
Brittinger G; Bartels H; Bremer K; Burger A; Dühmke E; Gunzer U; König E; Stacher A; Stein H; Theml H; Waldner R
Strahlentherapie; 1977 Apr; 153(4):222-8. PubMed ID: 324031
[TBL] [Abstract][Full Text] [Related]
14. Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.
Guy K; Krajewski AS; Dewar AE
Br J Cancer; 1986 Feb; 53(2):161-73. PubMed ID: 3513812
[TBL] [Abstract][Full Text] [Related]
15. T-lymphoblastic and peripheral T-cell lymphomas in the northern part of The Netherlands. An immunologic study of 29 cases.
Hollema H; Poppema S
Cancer; 1989 Oct; 64(8):1620-8. PubMed ID: 2790674
[TBL] [Abstract][Full Text] [Related]
16. Deficient tumor-infiltrating T-lymphocyte response in malignant lymphoma: relationship to HLA expression and host immunocompetence.
List AF; Spier CM; Miller TP; Grogan TM
Leukemia; 1993 Mar; 7(3):398-403. PubMed ID: 7680400
[TBL] [Abstract][Full Text] [Related]
17. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
18. Low-grade lymphomas. Expression of developmentally regulated B-cell antigens.
Cossman J; Neckers LM; Hsu S; Longo D; Jaffe ES
Am J Pathol; 1984 Apr; 115(1):117-24. PubMed ID: 6201073
[TBL] [Abstract][Full Text] [Related]
19. Expression of major histocompatibility antigens and nature of inflammatory cellular infiltrate in ovarian neoplasms.
Kabawat SE; Bast RC; Welch WR; Knapp RC; Bhan AK
Int J Cancer; 1983 Nov; 32(5):547-54. PubMed ID: 6358053
[TBL] [Abstract][Full Text] [Related]
20. Immunophenotypic analysis of extranodal non-Hodgkin's lymphomas in the oral cavity.
Takahashi H; Fujita S; Okabe H; Tsuda N; Tezuka F
Pathol Res Pract; 1993 Apr; 189(3):300-11. PubMed ID: 8332573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
